Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Infection Control 2017

About Conference

With the grand success from the previous relevant annual International conferences, Conference Series LLC is organizing “Infection Control” (Infection Control 2017) scheduled during September 25-26, 2017 in Chicago, USA. Infection Control 2017 brings together the global leaders in infection control and relevant fields to present their research at this exclusive scientific program.

The infection control conference hosting presentations from editors of prominent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, immunology, microbiology, infection prevention and infection control. Infection Control 2017 Organizing Committee also invites young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.

Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CDI, SSI, CRE, MRSA, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Who should attend?

•           Microbiologists

•           Bacteriologists

•           Virologists

•           Parasitologists

•           Mycologists

•           Pathologists

•           Pharmacists

•           Epidemiologists

•           Health Care Professionals

•           Infectious Diseases Specialists

•           Infection Prevention and Infection Control Specialists

Why to attend?

With members from around the world focused on learning about global trends on emerging infectious diseases and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3 days event. World renowned speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

Targeted Audience

•              Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

•              Infectious Diseases Researchers, Scientists, Faculties, Students

•              Infectious Diseases Associations and Societies

•              Medical Colleges

•              Pharmaceutical Companies and Industries

•              Medical Devices Manufacturing Companies

•              Drug Manufacturing Companies and Industries

•              Laboratory Technicians and Diagnostic Companies

•              Business Entrepreneurs and Industrialists

•              Training Institutes

•              Software Developing Companies

•              Data Management Companies

For Scientific Sessions please go through the link:

http://infectioncontrol.conferenceseries.com/call-for-abstracts.php

For Abstract Submission please go through the link:

http://infectioncontrol.conferenceseries.com/abstract-submission.php

Sessions/Tracks

Track 1:  Infection Treatment and Prevention Control

The infections caused by germs and which may infect any part of the body are called infectious diseases. Diseases such as cancer can be treated by chemotherapy. Infection prevention and control is helpful to prevent the transmission of infectious diseases. Some infectious diseases can be prevented by avoiding direct contact with the contagious person.  Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Recent techniques have proved that there is no disease that cannot be treated.

Track 2:  Infection Novel Therapies

Infectious Diseases and Therapy is of high-quality preclinical, clinical, observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.  The Global Infection Control in Cancer Therapy Market is poised to grow at a CAGR of around 15.5% over the forecast period 2015 to 2025.

Track 3: Surveillance Practice for MRSA

MRSA has emerged as one of the predominant pathogens in healthcare-associated infections. Treatment options for MRSA are limited and less effective than options available for susceptible S. aureus infections and result in higher morbidity and mortality. Hospitals are debating whether to swab every patient upon admission for Methicillin-Resistant Staphylococcus aureus, or just every patient admitted to the intensive care unit, or just certain patient populations such as those undergoing dialysis or those in pediatric settings. Current estimates suggest that 49-65% of healthcare-associated S. aureus infections reported to NHSN are caused by methicillin- resistant strains.

Track 4:  Infection Control in Intravenous Therapy/Physical Therapy

The insertion, maintenance, and surveillance of intravenous systems require close attention by both physicians and nurses. Improvements are needed. Only with the combined efforts of all concerned will the hazards of intravenous therapy be reduced. The World Confederation for Physical Therapy (WCPT) advocates that infection prevention and control is the responsibility of all those involved in health services delivery and should be embedded into everyday practice.  This relates to health service acquired infections and those that result from other sources, not just those that are considered high-risk infectious diseases. Early diagnosis, along with strategies to manage and contain infections, is essential for the wellbeing of patients/clients and all health professionals. 

Track 5:  Resistance and Emerging Infectious Organisms

Emerging antimicrobial resistance among hospital pathogens has typically become endemic, but clustered outbreaks certain occur.  Detailed microbial descriptions and pathogen epidemiology by reference laboratories, such as the WRAIR’s Multi-Drug Organism Resistance and Surveillance Network (MRSN), are well established. An Infectious disease whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Track 6:  Control of Organs Transplatantation Infection

As complications from infection are a major cause of morbidity and mortality following transplantation, infection prevention is a cornerstone of any modern solid organ transplantation program. This topic is not a thorough analysis of all studies examining the prevention of infection following organ transplantation, but a practical guide to widely accepted recommendations regarding the prevention of common infections in the transplant setting, such as bacterial infections, including tuberculosis, cytomegalovirus, hepatitis viruses or invasive fungal infections.

Track 7:  Food and Drug Administration

The FDA is renowned for its work in regulating the development of new drugs. The FDA has developed rules regarding the clinical trials that must be done on all new drugs. Currently, pharmaceutical companies must test drugs through four phases of clinical trials before they can be marketed to individuals.  Resubmission of failed applications is costly, delaying marketing approval and the availability of new drugs to patients. The full economic impact analyses of significant FDA regulations are no longer published in the Federal Register but are available on this site.

Track 8:  Pediatric Infections Prevention and Control

Pediatric infections/ childhood infections are the infections which are caused in children of different age groups. Pediatric infections specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults. 11 million children deaths every year are attributable to six causes: diarrhoea, malaria, neonatal infection, pneumonia, preterm delivery, or lack of oxygen at birth. Some of the deaths occur from illnesses like measles, malaria or tetanus. Others result indirectly from marginalization, conflict and HIV/AIDS. Global burden of Pediatric mortality is increasing drastically every year. 

Track 9:  Infection Control Products/Infection Rates

Consistency and streamlined processes are critical to infection control and prevention. Solutions for reducing hospital-acquired infections must be intuitive, efficient and easy to implement. Our infection prevention portfolio includes products to address: catheter-associated urinary tract infections (CAUTI), central line-associated blood stream infections (CLABSI), surgical site infections (SSI), pneumonia prevention (HAP and VAP) and surface disinfection. infection rates are frequently calculated by dividing the number of infections acquired during a month by the number of patients discharged during that month. On the basis of the rate of infections per patient-day, it is possible to test for interhospital and intrahospital differences as well as for differences over time.

Track 10:  Influenza Related Illness/Influenza Virus

The influenza vaccine is less effective in the elderly. It is unknown whether influenza vaccination of nonelderly adults confers additional disease protection on the elderly population.  In a large, nationwide sample of Medicare beneficiaries, influenza vaccination among adults aged 18–64 years was inversely associated with illnesses related to influenza in the elderly. This year, the global market for products used in the fight against influenza will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Influenza Market, from BCC Research. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018.

Track 11: Smallpox/ Chickenpox Infection Control

Smallpox is a serious, contagious, and sometimes fatal infectious disease. There is no proven treatment for smallpox disease. Prevention is achieved through vaccination. For purposes of controlling a smallpox outbreak, smallpox vaccine and antivirals can be used. Chikungunya is a febrile infection that resembles dengue which occurs especially in parts of Africa, India and South Eastern Asia caused by a toga virus of the genus aphavirus (species chikungunya virus) and transmitted by mosquitoes especially of the genus aedes.

Track 12:  Fungal Infections/Germs

The infections caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection. The infection control market in cancer therapy is expected to have a huge growth potential in next few years.  Additionally, growing healthcare awareness among the population and poor sanitation conditions in underdeveloped countries further expected to boost the market.

Track 13:  Rabies/Ebola Viral Infections Control

Rabies is an infectious viral disease that is almost always fatal following the onset of clinical signs. In up to 99% of human cases, the rabies virus is transmitted by domestic dogs. Rabies affects domestic and wild animals, and is spread to people through bites or scratches, usually via saliva. .Ebola viral infection is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola virus disease symptoms are very severe which appears in 2-3 days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.

Track 14:  Control of Infections during Pregnancy

Infections in a mother-to-be can sometimes lead to birth defects in her unborn child. Maintaining proper hygiene and taking a few extra precautions can sometimes mean the difference between a healthy, happy baby and a life-threatening illness. Use of intermittent preventative treatment in pregnancy and using nets resulted in an estimated 94,000 new born deaths being averted between 2009 and 2012 in 25 African countries. If these interventions had been applied to 80% of the at-risk population, it is estimated that 300,000 deaths could have been prevented.

Track 15:  Infection by Zoonosis

Animal infections/ zoonosis are important threat to human health since the emergence of human diseases is dominated by zoonotic pathogens. Infectious diseases affect livestock and also wild animals focusing on characterizing the conditions for the pathogen spread and maintenance in the host population. Scientist’s assessment about the zoonotic diseases are that more than 8 out of every 12 known infectious diseases in humans are spread from faunas, and 4 out of every 5 new or emerging infectious diseases in people are spread from faunas. Yearly, estimated, thousands of Americans gets sick from diseases spread between faunas and humans. Because of this, the national health agency works 24/7 to protect people from zoonotic diseases.

Track 16:  Practices and Awareness of Infection Control

Public awareness refers to the important role that community enthusiasm and knowledge has in building sustainable societies. Delivering knowledge to remote communities requires strategies for effective communication regarding infections prevention and control and maintenance of good hygienic conditions by creating healthy environment and infection free world. The growing aging population, with associated rise in the incidence of chronic diseases have also led to an increased demand of infection control products. However, factors such as stringent regulatory requirements and the need to comply with them may restrain the growth of infection control market to a certain extent.

Track 17:  Surgical Infections Control

Surgical Infections provides comprehensive and authoritative information on the biology, prevention, and management of post-operative infections. Original articles cover the latest advancements, new therapeutic management strategies, and translational research that is being applied to improve clinical outcomes and successfully treat post-operative infections. The Global Surgical and Infection Control Device market has experienced significant growth during the last five years and is expected to continue its growth momentum, reaching approximately US $84 billion in 2017 with a CAGR of 6.6% over the next five years.

Track 18:  Respiratory and Pulmonary Infections Prevention and Control

 Respiratory tract infections are the infections which are observed in the respiratory tract ad they are further classified as upper respiratory tract infections and lower respiratory tract infections. Pulmonary infections are mostly observed in lungs which in turn causes acute bronchitis or pneumonia which are often caused by viruses but also can be caused by bacteria or fungal organisms. In COPD patients requiring intubation and invasive MV for hypercapnic respiratory failure, which is exacerbated by pulmonary infection, early extubation followed by noninvasive MV initiated at the start of PIC window may decrease significantly the duration of invasive MV, the risk of VAP and hospital mortality.

Track 19:  Control of Zika/Malaria/Dengue Viral Infections

Zika viral infection is caused by a virus transmitted primarily by aedes mosquitoes. People with zika virus disease can have symptoms including mild fever, skin rash, conjunctivitis, muscle and joint pain and malaise or headache.  Malaria is a mosquito borne infection affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases it can cause yellow skin, seizures, comaor and even death. Dengue is a debilitating viral infection of the tropics, transmitted by mosquitoes which inturn causes sudden fever and acute pains in the joints. 

Track 20:  Disinfecting with UV Technology

UV disinfection is effective at wavelengths from 200 nm to 300 nm. The UVC radiation emitted has a strong bactericidal effect. It is absorbed by the DNA, destroys its structure and inactivates living cells. Microorganisms such as viruses, bacteria, yeasts and fungi are rendered harmless within seconds by UV radiation. If the irradiance is high enough, UV disinfection is a reliable and environmentally-friendly method because chemicals need not be added. Moreover, the microorganisms cannot become resistant to UV radiation.

Track 21: Control of HIV/AIDS from STDs & STIs

Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV). Sexually transmitted diseases/ sexually transmitted infections are the infections which are transmitted through sexual contact with an infected individual and also transmitted during vaginal or other types of sexual intercourse including oral and anal sex. In many countries, basic STI services are in disarray as programme resources are determined by decisions relating to a single disease entity. Major HIV epidemics emerged from and spread rapidly under conditions of poor STI control, and further weakening of STI control may well undermine other HIV prevention efforts.

Track 22: Infection Control from Plants

Plant diseases have caused severe losses to humans in several ways. Starvation and uprooting of families resulted from the Irish famine caused by potato late blight. A valued resource was lost with the virtual elimination of the American chestnut by chestnut blight (caused by Cryphonectria parasitica). And direct economic loss such as the estimated one billion dollars lost in one year to American corn growers from southern corn leaf blight. Many plant diseases cause less dramatic losses annually throughout the world but collectively constitute sizable losses to farmers and can reduce the aesthetic values of landscape plants and home gardens.

 

 

Market Analysis

Infection Control Therapeutic Market

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Infection Control Market worth 17.78 Billion USD by 2021

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America. America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. . The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. The report "Infection Control Market by Disinfection (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks) Sterilization (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services) End User (Hospitals, Lifescience) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa in the coming years.

Why Chicago?

Chicago is the third most populous city in both the U.S. state of Illinois and the American Midwest with an average population around 2.7 million. . The city lies within the humid continental climate zone and with seasonal variations.  The city is an international hub for finance, commerce, industry, technology, telecommunications, and transportation. Chicago was listed as an alpha global city by the Globalization and World Cities Research Network. The institutions in and around Chicago consistently rank among the top "National Universities" some of the top ranked universities in Chicago include- North-western University; The University of Chicago; Illinois Institute of Technology; Loyola University Chicago; and University of Illinois at Chicago. Some schools include: Chicago State University; North Park University; Columbia College Chicago; North-eastern Illinois University; Roosevelt University; Saint Xavier University; and Rush University. A lot of scope for research is there in and around Chicago exclusively in the sectors of Science and technology and in the field of medicine. There is also research going on in the areas of banking and finance. Scientists from top universities contribute world class research through the Chicago conferences, workshops and symposiums wherein and professionals from business take part with Great Spirit and add glory to the meetings and workshops organized by OMICS Group International.

Members Associated with Infection Control

  1. Infection Prevention Society around 2,000 members
  2. The Association for Professionals in Infection Control and Epidemiology (APIC) is the leading professional association for infection preventionists (IPs) with more than 15,000 members
  3. LSHTM_Control of Infectious Diseases has 19 members
  4. Global Public Health is having 106913 members

Societies and Associations related to Infection Control

  1. Association for Professionals in Infection Control and Epidemiology (APIC)
  2. Asia Pacific Society of Infection Control (APSIC)
  3. Ho Chi Minh Society of Infection Control (Vietnam)
  4. Indonesian Society of Infection Control
  5. Korean Society of Nosocomial Infection Control(KOSNIC)
  6. Sri Lanka Infection Control Nurses Association
  7. Taiwan Infection Control Society (ICST)
  8. The Infectious Diseases Society of Taiwan (IDST)
  9. Borneo Malaysia Infection Control and Antimicrobial Society Kota Kinabalu,
  10. Infection Control Association of Singapore
  11. Australasian College of Infection Prevention and Control (ACIPC)
  12. Malaysia Infection Control Association
  13. Hong Kong Infection Control Nurses Association (HKICNA)

Universities related to Infection Control

  1. University of Illinios-Chicago
  2. University of Toledo
  3. University of south Florido
  4. University of California, Berkerly
  5. Drexel University
  6. Colombia University, New York
  7. University of Washington
  8. Texas A&M Health Science Centre
  9. Tulane University
  10. Loma Linda University
  11. University of Minnesota-Twin Cities
  12. University of South Carolina
  13. Rutgers University-New Jersy
  14. University of Arizona

 

 

 

To Collaborate Scientific Professionals around the World

Conference Date Sep 25-26, 2017

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Journal of Infectious Diseases and Therapy Air and Water Borne Diseases Journal of Bacteriology and Parasitology Journal of Immunological Techniques in Infectious Diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by